PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.\', \'Assistant Professor of Biostatistics, Department of Statistics and Epidemiology, Faculty of Public Health, Tabriz University of Medical Sciences, Tabriz, Iran.\', \'Department of Clinical Pharmacy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: tentezari@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0014-2999(21)00079-010.1016/j.ejphar.2021.173926
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33549577
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
?:title
  • Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33549577>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33549577>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all